Last updated: June 6, 2026
VIENVA suppliers: who manufactures and supplies the ethinylestradiol/levonorgestrel contraceptive pill?
VIENVA is a combined oral contraceptive (COC) containing ethinylestradiol and levonorgestrel. Commercial supply is tied to the FDA-approved drug product label and its marketed manufacturer(s) listed in FDA records (commonly reflected in the NDC labeler / applicant / manufacturer fields).
VIENVA suppliers: who manufactures VIENVA in the US?
VIENVA is supplied in the US by the label’s listed manufacturer(s) (drug substance and drug product manufacturing are typically split across specialty contractors, but FDA drug product supply is tracked under the labeled manufacturer for the marketed dosage form).
Core supplier roles for VIENVA typically include:
- Applicant/labeler: entity responsible for the approved NDA labeling and marketed product
- Drug product manufacturer: final dosage-form manufacturing and release
- Contract manufacturing organization (CMO): tablet/capping, packaging, secondary packaging, and labeling
- Logistics and distribution: wholesaler distribution network supporting retail and institutional channels
What company is the MAH/applicant for VIENVA?
The MAH/applicant is the NDA holder / labeler shown in FDA labeling and the marketed product listing. That entity controls the supplier list through commercial contracts and change notifications.
Which NDC labeler data identifies VIENVA suppliers?
The most direct supplier mapping is via NDC Directory labeler/manufacturer fields for VIENVA dosage form strengths. Those fields identify:
- the labeler who owns the NDC listing
- the named manufacturing site(s) for that NDC
VIENVA manufacturers by strength and dosage form
VIENVA is marketed as a tablet. Supplier assignments can differ by:
- NDC strength (if multiple)
- market package configuration
- site of manufacture (site changes can occur through FDA CBE-30/supplements)
How do VIENVA suppliers change over time with FDA approvals and site transfers?
COC supply chains often show periodic transitions due to:
- manufacturing site transfers
- packaging line changes
- regulatory updates (CMC supplements, relabeling, or alternate suppliers)
When a new site is approved or an alternate is added, the change typically shows up as:
- updated NDC labeler/manufacturer details
- updated label revision dates
- updated FDA listing for the affected NDC(s)
What patent estate and regulatory status affects VIENVA supplier competition?
Even when manufacturing capability exists, supplier diversification is constrained by:
- FDA market exclusivity and any remaining protection (including method-of-use or formulation patents, if applicable)
- Orange Book listed patents tied to the marketed product
- potential ANDA/505(b)(2) route requirements for generics and authorized generics
What is VIENVA’s Orange Book status?
Orange Book listings (patent and exclusivity) govern whether a competitor can rely on the same reference product without legal risk. Supplier entry is often aligned with:
- ANDA timing
- any Paragraph IV litigation strategy (if present)
- settlement terms (if any)
What generic entry risks exist for VIENVA that impact supplier sourcing?
If VIENVA faces generic entry, the commercial supplier landscape can shift quickly due to:
- accelerated demand for equivalent products
- re-sourcing of contract manufacturers
- pricing pressure and inventory allocation
Key Takeaways
- VIENVA supplier identification in the US is driven by the NDC Directory labeler/manufacturer fields tied to the marketed tablet dosage forms.
- Supplier composition can change due to manufacturing site transfers and CMC supplements, which show up in updated NDC/manufacturer listings.
- Competitor manufacturing and sourcing are indirectly influenced by Orange Book patent and exclusivity status, which determines timing and legal risk for generic/505(b)(2) entrants.
FAQs
- How do I find the exact VIENVA manufacturer for a specific NDC? Use the VIENVA NDC in the FDA NDC Directory to read the labeler and listed manufacturer/site fields.
- Do VIENVA suppliers differ by package size or NDC? Yes. Different NDCs (even within the same strength) can map to different labeled manufacturers or packaging suppliers.
- Can VIENVA be made by contract manufacturers? Commonly yes. The named FDA drug product manufacturer in NDC listings reflects the site responsible for final release, even if work is contracted.
- How does FDA labeling indicate VIENVA supply chain responsibility? The label lists the drug product manufacturer and/or applicant responsible for the marketed product.
- What drives changes in VIENVA supplier listings? CMC supplements, manufacturing site additions, packaging line changes, and regulatory updates.
References
- FDA. NDC Directory. U.S. Food and Drug Administration.
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
- FDA. Drug Label Information for VIENVA (ethinylestradiol and levonorgestrel). U.S. Food and Drug Administration.
